Vaalia reimagines medication management for specialty care by integrating human coaching with Causal AI. The platform helps patients manage complex regimens, stay on therapy, and achieve better outcomes through personalized, evidence-driven support. Vaalia partners with providers and pharmaceutical companies to deliver actionable insights and improve adherence across the treatment journey.
Funding
Funding not disclosed
Founders
Product
Problem
Patients prescribed oral cancer medications frequently struggle with adherence, leading to suboptimal treatment outcomes and reduced drug effectiveness. Identifying the specific, individual-level reasons for non-adherence remains a challenge for healthcare providers.
Solution
Vaalia Health offers a platform leveraging Causal AI to predict individual risks and drivers of non-adherence to oral cancer medications. By analyzing patient-specific clinical and behavioral data, the platform uncovers the underlying causes of non-adherence for each patient. This enables healthcare professionals to proactively intervene with tailored support and resources, ultimately improving medication adherence and treatment effectiveness. The platform aims to provide actionable insights that lead to better patient outcomes and optimized drug utilization.
Target Audience
The primary target audience includes oncologists, pharmacists, and other healthcare professionals involved in the care of patients prescribed oral cancer medications, as well as pharmaceutical companies seeking to improve drug adherence.
Features
- Causal AI engine that identifies individual-level drivers of medication non-adherence
- Analysis of patient clinical data, behavioral data, and social determinants of health
- Predictive risk scores for non-adherence, enabling proactive intervention
- Personalized recommendations for interventions tailored to each patient's specific needs
- Integration with existing electronic health record (EHR) systems